| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |